Exploring Phytocannabinoids as Drug Candidates: Case Studies for Sleep, Pain, and Inflammation
Time: 9:15 am
day: Pre-Conference Day
Details:
Phytocannabinoids, known for their interaction with cannabinoid receptors (CB1 and CB2) as well as cannabinoid-like receptors (GPR55, GPR18, etc.), show significant promise as therapeutic agents for various health conditions. This workshop delves into the role of phytocannabinoids in modulating sleep, managing pain, and reducing inflammation, with an emphasis on the therapeutic potential of cannabinol (CBN), cannabidiol (CBD), and cannabigerol (CBG). Attendees will gain insights into existing research on these compounds' effects and explore the possibilities of using phytocannabinoid scaffolds to create new chemical entities (NCEs) in drug discovery. This session aims to foster understanding and discussion on the potential health benefits of phytocannabinoids and NCEs derived from phytocannabinoid scaffolds.
Address critical questions, such as
- What are the current limitations in the efficacy and safety data surrounding phytocannabinoids?
- Which methodologies are most effective for developing novel cannabinoid-based drugs, and what challenges arise in translating preclinical data to clinical success?
- How can we ensure that cannabinoid-based drug development remains targeted and precise to address specific disease states without unintended psychoactive effects?
- How can phytocannabinoid scaffolds be optimized to enhance interaction with cannabinoid and cannabinoid-like receptors for improved therapeutic outcomes?
